Cerebrospinal fluid neuropeptides in mood disorder and dementia
- PMID: 1352520
- DOI: 10.1016/0165-0327(92)90091-j
Cerebrospinal fluid neuropeptides in mood disorder and dementia
Abstract
Cerebrospinal fluid (CSF) concentrations of immunoreactive corticotropin-releasing hormone (CRH) and somatostatin (SRIF) were measured in female psychiatric inpatients with DSM-III-R diagnoses of major depression, mania, generalized anxiety and somatization disorder. In addition, elderly patients with dementia disorders, with or without concomitant major depression, were also investigated. CSF SRIF was not significantly different among these groups; on the other hand, mean CSF CRH concentrations were significantly higher in major depression and in dementia with depression as compared with neurological controls with no psychiatric disorders. CSF CRH levels in mania, simple dementia, or anxiety or somatization disorder were not significantly different from the controls. Background physical or clinical variables did not account for the differences in CRH concentrations. It is concluded that CSF CRH elevation may be present in some patients with major depression independent of age and an underlying dementia disorder.
Similar articles
-
Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.Neuropsychobiology. 1992;26(1-2):37-42. doi: 10.1159/000118894. Neuropsychobiology. 1992. PMID: 1361969
-
CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.Psychoneuroendocrinology. 1993;18(7):509-19. doi: 10.1016/0306-4530(93)90044-l. Psychoneuroendocrinology. 1993. PMID: 7903467
-
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.Neuroendocrinology. 1993 Jan;57(1):79-88. doi: 10.1159/000126345. Neuroendocrinology. 1993. PMID: 8097579
-
Corticotropin-releasing hormone in depression and post-traumatic stress disorder.Peptides. 2001 May;22(5):845-51. doi: 10.1016/s0196-9781(01)00399-0. Peptides. 2001. PMID: 11337099 Review.
-
Stress responsive neurohormones in depression and anxiety.Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S207-14. doi: 10.1055/s-2003-45132. Pharmacopsychiatry. 2003. PMID: 14677081 Review.
Cited by
-
The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.Eur Arch Psychiatry Clin Neurosci. 2010 Dec;260(8):583-600. doi: 10.1007/s00406-010-0108-z. Epub 2010 Feb 20. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 20174927 Review.
-
Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates.Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15749-54. doi: 10.1073/pnas.232480899. Epub 2002 Nov 18. Proc Natl Acad Sci U S A. 2002. PMID: 12438692 Free PMC article.
-
The CRF system, stress, depression and anxiety-insights from human genetic studies.Mol Psychiatry. 2010 Jun;15(6):574-88. doi: 10.1038/mp.2009.141. Epub 2009 Dec 15. Mol Psychiatry. 2010. PMID: 20010888 Free PMC article. Review.
-
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.Horm Behav. 2006 Nov;50(4):550-61. doi: 10.1016/j.yhbeh.2006.06.019. Epub 2006 Jul 25. Horm Behav. 2006. PMID: 16870185 Free PMC article. Review.
-
Depression and antidepressants: molecular and cellular aspects.Cell Mol Life Sci. 2009 Sep;66(18):2985-3008. doi: 10.1007/s00018-009-0055-x. Epub 2009 Jun 12. Cell Mol Life Sci. 2009. PMID: 19521663 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical